Vikram Purohit

Stock Analyst at Morgan Stanley

(1.75)
# 3,395
Out of 5,045 analysts
159
Total ratings
31.75%
Success rate
-8.61%
Average return

Stocks Rated by Vikram Purohit

Zenas BioPharma
Oct 28, 2025
Maintains: Overweight
Price Target: $31$34
Current: $31.19
Upside: +9.01%
Halozyme Therapeutics
Oct 20, 2025
Maintains: Overweight
Price Target: $80$79
Current: $65.24
Upside: +21.09%
Absci
Aug 18, 2025
Maintains: Overweight
Price Target: $6.4$5.89
Current: $4.31
Upside: +36.82%
Recursion Pharmaceuticals
Jul 3, 2025
Assumes: Equal-Weight
Price Target: $5
Current: $5.54
Upside: -9.67%
Ascendis Pharma
May 5, 2025
Upgrades: Overweight
Price Target: $180$250
Current: $202.20
Upside: +23.64%
Incyte
Mar 24, 2025
Maintains: Equal-Weight
Price Target: $69$65
Current: $93.55
Upside: -30.52%
Axsome Therapeutics
Feb 27, 2025
Maintains: Overweight
Price Target: $125$190
Current: $134.18
Upside: +41.60%
Foghorn Therapeutics
Sep 24, 2024
Maintains: Equal-Weight
Price Target: $6$9
Current: $4.33
Upside: +108.09%
Genmab
Sep 11, 2024
Maintains: Equal-Weight
Price Target: $31
Current: $28.50
Upside: +8.77%
ABIVAX Société Anonyme
Apr 11, 2024
Maintains: Equal-Weight
Price Target: $15$16
Current: $104.02
Upside: -84.62%
Initiates: Overweight
Price Target: $30
Current: $6.38
Upside: +370.59%
Maintains: Overweight
Price Target: $45$10
Current: $25.02
Upside: -60.03%
Downgrades: Equal-Weight
Price Target: $46$6
Current: $8.16
Upside: -26.43%
Maintains: Overweight
Price Target: $43$42
Current: $12.90
Upside: +225.71%
Maintains: Equal-Weight
Price Target: $38$41
Current: $61.97
Upside: -33.84%
Maintains: Equal-Weight
Price Target: $120$40
Current: $17.12
Upside: +133.71%
Initiates: Equal-Weight
Price Target: $13
Current: $3.08
Upside: +322.08%
Maintains: Equal-Weight
Price Target: $39$38
Current: $20.68
Upside: +83.75%
Maintains: Equal-Weight
Price Target: $24$20
Current: $11.56
Upside: +73.01%
Maintains: Underweight
Price Target: $11$10
Current: $14.59
Upside: -31.46%
Initiates: Overweight
Price Target: $22
Current: $1.95
Upside: +1,028.15%
Maintains: Equal-Weight
Price Target: $40$20
Current: $14.62
Upside: +36.80%